Breaking News

Frontage Labs Achieves CMC Milestone

FDA completes review with no 483 citations

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Frontage Laboratories, Inc. has met FDA standards for testing commercial products in its Chemistry, Manufacturing and Controls (CMC) labs for the fourth time in four years. The FDA completed the annual review of CMC Quality and Lab Systems with no Form 483 citations. As a result, the Exton, PA, facilities maintain certification as commercial testing labs. “We make it a priority to build in quality from start to finish for every project,” said Song Li, Ph.D., Frontage’s founder and chief executi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters